Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 59

1.

The challenge of improving the diagnostic yield from metanephrine testing in suspected phaeochromocytoma and paraganglioma.

Samsudin I, Page MM, Hoad K, Chubb P, Gillett M, Glendenning P, Vasikaran S.

Ann Clin Biochem. 2018 Nov;55(6):679-684. doi: 10.1177/0004563218774590. Epub 2018 May 2.

PMID:
29660998
2.

Clinical utility of bone turnover markers in the management of common metabolic bone diseases in adults.

Glendenning P, Chubb SAP, Vasikaran S.

Clin Chim Acta. 2018 Jun;481:161-170. doi: 10.1016/j.cca.2018.03.009. Epub 2018 Mar 12. Review.

PMID:
29544749
3.

Improved technical success and radiation safety of adrenal vein sampling using rapid, semi-quantitative point-of-care cortisol measurement.

Page MM, Taranto M, Ramsay D, van Schie G, Glendenning P, Gillett MJ, Vasikaran SD.

Ann Clin Biochem. 2018 Sep;55(5):588-592. doi: 10.1177/0004563218760352. Epub 2018 Feb 22.

PMID:
29388434
4.

Isolated brachydactyly type E and idiopathic pancreatitis in a patient presenting to a lipid disorders clinic.

Page MM, Hooper AJ, Glendenning P, Burnett JR.

BMJ Case Rep. 2017 Apr 6;2017. pii: bcr-2016-218825. doi: 10.1136/bcr-2016-218825.

5.

25-Hydroxyvitamin D C3-epimer is universally present in neonatal Western Australian samples but is unlikely to contribute to diagnostic misclassification.

Cooke DJ, Cooke BR, Bell DA, Vasikaran SD, Glendenning P.

Ann Clin Biochem. 2016 Sep;53(Pt 5):593-8. doi: 10.1177/0004563215625693. Epub 2015 Dec 17.

PMID:
26684022
6.

Measuring vitamin D.

Glendenning P.

Aust Prescr. 2015 Feb;38(1):12-5. Epub 2014 Nov 24. Review.

7.

Controversy and consensus regarding vitamin D: Recent methodological changes and the risks and benefits of vitamin D supplementation.

Glendenning P, Inderjeeth CA.

Crit Rev Clin Lab Sci. 2016;53(1):13-28. doi: 10.3109/10408363.2015.1074157. Epub 2015 Sep 17.

PMID:
26377861
8.

Controversies and consensus regarding vitamin D deficiency in 2015: whom to test and whom to treat?

Glendenning P, Chew GT.

Med J Aust. 2015 May 18;202(9):470-1. No abstract available.

PMID:
25971562
9.

Is vitamin D testing at a tertiary referral hospital consistent with guideline recommendations?

Norton K, Vasikaran SD, Chew GT, Glendenning P.

Pathology. 2015 Jun;47(4):335-40. doi: 10.1097/PAT.0000000000000267.

PMID:
25938355
10.

Long-term efficacy, safety, and patient acceptability of ibandronate in the treatment of postmenopausal osteoporosis.

Inderjeeth CA, Glendenning P, Ratnagobal S, Inderjeeth DC, Ondhia C.

Int J Womens Health. 2014 Dec 17;7:7-17. doi: 10.2147/IJWH.S73944. eCollection 2015. Review.

11.

Investigating hypophosphataemia.

Glendenning P, Bell DA, Clifton-Bligh RJ.

BMJ. 2014 May 28;348:g3172. doi: 10.1136/bmj.g3172. No abstract available.

PMID:
24871308
12.

Prolonged vitamin D intoxication: presentation, pathogenesis and progress.

Bell DA, Crooke MJ, Hay N, Glendenning P.

Intern Med J. 2013 Oct;43(10):1148-50. doi: 10.1111/imj.12269.

PMID:
24134173
13.

A diagnostic conundrum: heterophilic antibody interference in an adrenocorticotropic hormone immunoassay not detectable using a proprietary heterophile blocking reagent.

Grasko J, Willliams R, Beilin J, Glendenning P, Fermoyle S, Vasikaran S.

Ann Clin Biochem. 2013 Sep;50(Pt 5):433-7. doi: 10.1177/0004563213487514. Epub 2013 Jul 19.

PMID:
23873871
14.

Calculated free and bioavailable vitamin D metabolite concentrations in vitamin D-deficient hip fracture patients after supplementation with cholecalciferol and ergocalciferol.

Glendenning P, Chew GT, Inderjeeth CA, Taranto M, Fraser WD.

Bone. 2013 Oct;56(2):271-5. doi: 10.1016/j.bone.2013.06.012. Epub 2013 Jun 20.

PMID:
23792937
15.

It is time to start ordering ionized calcium more frequently: preanalytical factors can be controlled and postanalytical data justify measurement.

Glendenning P.

Ann Clin Biochem. 2013 May;50(Pt 3):191-3. doi: 10.1177/0004563213482892. No abstract available.

PMID:
23610214
16.

What is the therapeutic target level of 25-hydroxyvitamin D in osteoporosis and how accurately can we measure it?

Glendenning P, Prince RL.

Intern Med J. 2012 Oct;42(10):1069-72. doi: 10.1111/j.1445-5994.2012.02908.x. No abstract available.

PMID:
23046188
17.

Vitamin D: methods of 25 hydroxyvitamin D analysis, targeting at risk populations and selecting thresholds of treatment.

Glendenning P, Inderjeeth CA.

Clin Biochem. 2012 Aug;45(12):901-6. doi: 10.1016/j.clinbiochem.2012.04.002. Epub 2012 Apr 11. Review.

PMID:
22522083
18.

Screening for vitamin D deficiency: defining vitamin D deficiency, target thresholds of treatment and estimating the benefits of treatment.

Glendenning P, Inderjeeth CA.

Pathology. 2012 Feb;44(2):160-5. doi: 10.1097/PAT.0b013e32834e8df6. Review.

PMID:
22186673
19.

Effects of three-monthly oral 150,000 IU cholecalciferol supplementation on falls, mobility, and muscle strength in older postmenopausal women: a randomized controlled trial.

Glendenning P, Zhu K, Inderjeeth C, Howat P, Lewis JR, Prince RL.

J Bone Miner Res. 2012 Jan;27(1):170-6. doi: 10.1002/jbmr.524.

20.

Improved plasma free metadrenaline analysis requires mixed mode cation exchange solid-phase extraction prior to liquid chromatography tandem mass spectrometry detection.

Clarke MW, Cooke B, Hoad K, Glendenning P.

Ann Clin Biochem. 2011 Jul;48(Pt 4):352-7. doi: 10.1258/acb.2011.010235. Epub 2011 Jun 20.

PMID:
21690275
21.

Association between 25-OH vitamin D and insulin is independent of lipoatrophy in HIV.

Hammond E, McKinnon E, Glendenning P, Williams R, Mallal S, Phillips E.

Clin Endocrinol (Oxf). 2012 Feb;76(2):201-6. doi: 10.1111/j.1365-2265.2011.04149.x.

PMID:
21682759
23.
24.

Association between 25-hydroxyvitamin D, somatic muscle weakness and falls risk in end-stage renal failure.

Boudville N, Inderjeeth C, Elder GJ, Glendenning P.

Clin Endocrinol (Oxf). 2010 Sep;73(3):299-304. doi: 10.1111/j.1365-2265.2010.03821.x. Epub 2010 Apr 30.

PMID:
20507339
25.

Delayed diagnosis of primary hyperaldosteronism.

Grasko JM, Nguyen HH, Glendenning P.

BMJ. 2010 May 25;340:c2461. doi: 10.1136/bmj.c2461. No abstract available.

PMID:
20501556
26.

Serum 25-hydroxyvitamin D levels in vitamin D-insufficient hip fracture patients after supplementation with ergocalciferol and cholecalciferol.

Glendenning P, Chew GT, Seymour HM, Gillett MJ, Goldswain PR, Inderjeeth CA, Vasikaran SD, Taranto M, Musk AA, Fraser WD.

Bone. 2009 Nov;45(5):870-5. doi: 10.1016/j.bone.2009.07.015. Epub 2009 Jul 23.

PMID:
19631774
27.

Developments in multicavity hot runner tooling.

Glendenning P.

Med Device Technol. 2009 May-Jun;20(3):36-8.

PMID:
19626955
28.

Thyroxine autoantibody interference is an uncommon cause of inappropriate TSH secretion using the Immulite 2000 assay.

Glendenning P, Siriwardhana D, Hoad K, Musk A.

Clin Chim Acta. 2009 May;403(1-2):136-8. doi: 10.1016/j.cca.2009.02.002. Epub 2009 Feb 10.

PMID:
19361452
29.

Selective monitoring of vitamin D2 and D3 supplementation with a highly specific 25-hydroxyvitamin D3 immunoassay with negligible cross-reactivity to 25-hydroxyvitamin D2.

Li B, Byrjalsen I, Glendenning P, Henriksen DB, Hoeck HC, Taranto M, Vasikaran S, Fraser WD, Christiansen C, Qvist P.

Clin Chim Acta. 2009 Jun 27;404(2):144-8. doi: 10.1016/j.cca.2009.03.043. Epub 2009 Mar 29.

PMID:
19336231
30.

Efficacy and safety of pharmacological agents in managing osteoporosis in the old old: review of the evidence.

Inderjeeth CA, Foo AC, Lai MM, Glendenning P.

Bone. 2009 May;44(5):744-51. doi: 10.1016/j.bone.2008.12.003. Epub 2008 Dec 16. Review.

PMID:
19130909
31.
32.

Endotoxin induced TNF and IL-10 mRNA production is higher in male than female donors: correlation with elevated expression of TLR4.

Temple SE, Pham K, Glendenning P, Phillips M, Waterer GW.

Cell Immunol. 2008 Feb;251(2):69-71. doi: 10.1016/j.cellimm.2008.04.013. Epub 2008 Jun 13.

PMID:
18555210
33.

The role of biochemical markers of bone turnover in osteoporosis management in clinical practice.

Vasikaran SD, Glendenning P, Morris HA.

Clin Biochem Rev. 2006 Aug;27(3):119-21. No abstract available.

34.

Current assays overestimate 25-hydroxyvitamin D3 and underestimate 25-hydroxyvitamin D2 compared with HPLC: need for assay-specific decision limits and metabolite-specific assays.

Glendenning P, Taranto M, Noble JM, Musk AA, Hammond C, Goldswain PR, Fraser WD, Vasikaran SD.

Ann Clin Biochem. 2006 Jan;43(Pt 1):23-30.

PMID:
16390606
35.
36.

Fit for a fracture.

Seymour HM, Glendenning P.

Med J Aust. 2005 Aug 15;183(4):213-4. No abstract available.

PMID:
16097924
37.

25-OH-vitamin D assays.

Glendenning P, Fraser WD.

J Clin Endocrinol Metab. 2005 May;90(5):3129. No abstract available.

PMID:
15872340
38.

8: Disorders of bone and mineral other than osteoporosis.

Prince RL, Glendenning P.

Med J Aust. 2004 Apr 5;180(7):354-9. Review.

PMID:
15059059
39.
40.

Estrogen and androgen regulation of plasma membrane calcium pump activity in immortalized distal tubule kidney cells.

Dick IM, Liu J, Glendenning P, Prince RL.

Mol Cell Endocrinol. 2003 Dec 30;212(1-2):11-8.

PMID:
14654246
41.
42.

Issues of standardization and assay-specific clinical decision limits for the measurement of 25-hydroxyvitamin D.

Glendenning P.

Am J Clin Nutr. 2003 Feb;77(2):522-3. No abstract available.

PMID:
12540418
43.

Low rate of compliance with ergocalciferol therapy in vitamin-D-deficient patients with hip fracture.

Noble JM, McGuiness M, Glendenning P.

Med J Aust. 2002 Sep 2;177(5):280. No abstract available.

PMID:
12197833
44.

Surgically correctable hypertension.

Glendenning P, Vasikaran SD.

Pathology. 2002 Jun;34(3):297-8. No abstract available.

PMID:
12109798
45.

The estimated prevalence of familial hypocalciuric hypercalcemia (FHH).

Glendenning P, Stuckey BG.

Calcif Tissue Int. 2002 Jun;70(6):512; author reply 512-3. Epub 2002 May 20. No abstract available.

PMID:
12016464
46.

Vitamin D deficiency and multicultural Australia.

Glendenning P.

Med J Aust. 2002 Mar 4;176(5):242-3; author reply 243. No abstract available.

PMID:
11999247
47.

Parathyroid hormone is more stable in EDTA plasma than in serum.

Glendenning P, Laffer LL, Weber HK, Musk AA, Vasikaran SD.

Clin Chem. 2002 May;48(5):766-7. No abstract available.

48.

Inappropriate thyroid-stimulating hormone secretion.

Glendenning P.

Intern Med J. 2002 Mar;32(3):120-1. No abstract available.

PMID:
11885841
49.

Preanalytical factors in the measurement of intact parathyroid hormone with the DPC IMMULITE assay.

Glendenning P, Musk AA, Taranto M, Vasikaran SD.

Clin Chem. 2002 Mar;48(3):566-7. No abstract available.

50.

Vitamin D status and redefining serum PTH reference range in the elderly.

Glendenning P, Vasikaran SD.

J Clin Endocrinol Metab. 2002 Feb;87(2):946-7. No abstract available.

PMID:
11836346

Supplemental Content

Loading ...
Support Center